Does Rallies track congressional trades in CLLS?

Yes. Rallies tracks politician and congressional stock disclosures for CLLS, including reported purchases, sales, dates, owners, and trade amounts when available.

Is CLLS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLLS. It does not provide personalized investment advice.

CLLS (Cellectis S.A. American Depositary Shares) Stock Analysis - Politician Trades

Cellectis S.A. American Depositary Shares (CLLS) is a publicly traded Healthcare sector company. As of May 21, 2026, CLLS trades at $3.65 with a market cap of $387.35M and a P/E ratio of 0.00. CLLS moved +0.83% today. Year to date, CLLS is -19.38%; over the trailing twelve months it is +137.66%. Its 52-week range spans $1.10 to $5.48. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces CLLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded CLLS stock?

Rallies tracks politician and congressional stock disclosures for CLLS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

CLLS Key Metrics

Key financial metrics for CLLS
Metric	Value
Price	$3.65
Market Cap	$387.35M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$5.48
52-Week Low	$1.10
Volume	11
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest CLLS News

Cellectis Posts $188 Million Cash, Cema-cel Delivers 58.3% MRD Negativity — May 11, 2026
Cellectis’ TALE Epigenetic Editors Achieve >90% Gene Knock-down in T-cells and Hepatocytes — Apr 27, 2026
Cellectis’ Cema-cel Achieves 58.3% MRD Negativity, No Severe AEs — Apr 13, 2026
Cellectis Reports $211M Cash Runway Into H2 2027 and 100% ORR in Phase 2 Trial — Mar 20, 2026
Analysts Forecast $14.9M Q4 Revenue and $0.24 EPS Loss at Cellectis SA — Mar 19, 2026

CLLS Analyst Consensus

1 analysts cover CLLS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about CLLS

Which politicians traded CLLS stock?: Rallies tracks politician and congressional stock disclosures for CLLS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CLLS?: Yes. Rallies tracks politician and congressional stock disclosures for CLLS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CLLS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLLS. It does not provide personalized investment advice.